BioSpace News Archive

XVIVO to Advance Their Digital Transformation Journey in Partnership with the World-Leading Cleveland Clinic to Increase the Number of Successful Lung Transplants

XVIVO and the Cleveland Clinic in the US have entered a partnership in advanced analytics, XPS Live, using lung perfusion data from XVIVO’s XPS machines.

May 18, 2022
·
3 min read
Business

LUCA Science and Kyowa Kirin Announce Joint Research Agreement on Mitochondrial Disease Treatment With Novel Mitochondria Modality

LUCA Science Inc. and Kyowa Kirin Co., Ltd. are pleased to announce they have entered into a research collaboration agreement on the treatment of mitochondrial diseases using platform of an innovative mitochondrial modality.

May 18, 2022
·
3 min read
Antengene Announces XPOVIO® Treatment Regimens Included for the First Time in the Guidelines for the Diagnosis and Management of Multiple Myeloma in China

Antengene Corporation Limited announces that the uses of XPOVIO® for Multiple Myeloma patients with first relapse or multiple relapses were incorporated into the Guidelines for the Diagnosis and Management of Multiple Myeloma in China.

May 18, 2022
·
7 min read
Business

Interim report January 1 - March 31, 2022

In the first quarter of 2022, license revenue rose 35 percent and support revenue rose 24 percent. Operating profit amounted to SEK 30 M.

May 18, 2022
·
43 min read
Pharm Country

Study Results Show Long-term Efficacy of iTind Procedure

Olympus announced the summary results of a follow-up study to measure the durability of the iTind™ procedure for treating the lower urinary tract symptoms caused by BPH.

May 18, 2022
·
4 min read
Drug Development

Keros Therapeutics Announces Preliminary Topline Results from its Ongoing Phase 1 Clinical Trial Evaluating KER-012 in Healthy Volunteers

Keros Therapeutics, Inc. announced preliminary topline results from Part 1 of its Phase 1 clinical trial evaluating single and multiple ascending doses of KER-012 in healthy postmenopausal volunteers.

May 18, 2022
·
6 min read
Genetown

Homology Medicines Presents Details of Optimized HMI-103 Nuclease-Free Gene Editing Candidate Featuring Integrated Liver-Specific Promoter to Maximize Long-Term Expression

Homology Medicines, Inc., a genetic medicines company, unveiled the mechanism of action and optimization of HMI-103, the nuclease-free gene editing candidate currently in a Phase 1 trial for phenylketonuria.

May 18, 2022
·
9 min read
Biotech Beach

Quantgene offers 12 hour RT-PCR COVID-19 tests for $99

Quantgene announced it can offer production companies COVID-19 RT-PCR tests for $99 at walk-in locations.

May 18, 2022
·
3 min read
Drug Development

XyloCor Therapeutics Announces Presentation of Preliminary Clinical Data from Phase 1 Portion of the EXACT Phase 1/2 Study of XC001 Novel Gene Therapy for Refractory Angina at AATS and ASGCT

XyloCor Therapeutics announced presentation of initial clinical data from the Phase 1 portion of its ongoing Phase 1/2 clinical trial for refractory angina at the American Association for Thoracic Surgery Annual Meeting on May 15, 2022, and at the American Society of Gene and Cell Therapy Annual Meeting on May 18, 2022.

May 18, 2022
·
6 min read
Biotech Beach

Viseon Inc. Announces Milestone of 1,000 U.S. Clinical Cases with MaxView® Intraoperative Realtime Spinal Imaging Technology

Viseon Inc. announced that it recently achieved over 1,000 U.S. Minimally Invasive Spine Surgery cases utilizing the Viseon MaxView Imaging Platform.

May 18, 2022
·
2 min read